Rosen Law Firm has announced an investigation into potential securities claims against Anavex Life Sciences Corp. following allegations that the company may have provided materially misleading business information to investors. This comes after Anavex's board terminated CEO Christopher Missling for cause, citing conduct inconsistent with company policy. Investors who purchased Anavex securities might be eligible for compensation through a class action lawsuit being prepared by the firm. Interested investors can join the class action without upfront fees via the Rosen Law Firm's website or contact details provided.
Regarding Anavex Life Sciences Corp. as of Sep 29, 2026 04:11 WIB, here is Pluang's market snapshot for the Health sector: Of 100 priced US health stocks, 52 rose and 47 fell today. Notable movers include Regeneron Pharmaceuticals Inc (REGN) at USD 750.00 with a 1-day change of -4.83% and a typical hold time of 106 days, Cassava Sciences Inc (FLNA) at USD 0.74 down 4.23% with 73% buy order activity, and Amphastar Pharmaceuticals Inc (AMPH) at USD 27.20 up 4.09% with 99% buy order activity. The most notable figure is REGN's price of USD 750.00.
Kodiak Sciences surged 178% following positive Phase III trial updates for a wet age-related macular degeneration treatment. Lifecore Biomedical rose 55% after agreeing to a $663.7 million acquisition by Webster Equity Partners. YD Bio gained 22%, li...
Several high-volume stocks including ITG Inc, Adicet Bio, Jaguar Health, Ocular Therapeutix, and Greenland Mines experienced sharp declines despite recent positive company news. The drops, ranging from about 19% to over 32%, appear driven by profit-t...
On September 28, 2026, Zcash (ZEC) price fell 8.5% to about $1,464 without any project-specific trigger. The decline coincided with a 13.5% drop in open interest on ZEC futures contracts at OKX, indicating leveraged positions were being closed rather...
Luckin Coffee is considering entering Gulf markets as part of its overseas expansion, supported by a $1 billion joint investment from Abu Dhabi's Mubadala sovereign wealth fund and Centurium Capital. The company, which has recovered from a past accou...
Solana's new consensus mechanism, Alpenglow, was expected to activate on mainnet on September 28, 2026, but this did not happen. The date referred to a general window for feature activations, not Alpenglow specifically. Developers confirmed that Alpe...
